Akanda Corp Acquires Holigen Limited

May 2, 2022

Akanda Corp entered into a definitive agreement to acquire 100% of Holigen Limited from The Flowr Corporation, adding cultivation, EU GMP manufacturing, and distribution capacity in Portugal. The deal was later reported as closed, positioning Akanda to accelerate its seed-to-patient model across EMEA and to scale toward adult-use opportunities as regulations evolve.

Buyers
Akanda Corp.
Targets
Holigen Limited, RPK Biopharma Unipessoal, Lda
Sellers
The Flowr Corporation
Location
Portugal
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.